Open AccessDevelopment of IgA vasculitis after SARS‐CoV ‐2 vaccination
Author(s) -
Ogura Yasuaki,
Morimoto Hiroki,
Otsuka Masaki,
Tokura Yoshiki
Publication year - 2022
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12242
Subject(s) - vaccination , vasculitis , immunology , medicine , immune system , virology , disease
We report a case of IgA vasculitis that occurred 1 week after COVID‐19 vaccination. Like influenza vaccine, SARS‐CoV‐2 vaccine is considered to have a potential to produce immune complexes with IgA. Given that patients with a history of IgA vasculitis may be flared up following SARS‐CoV‐2 vaccination, individuals with a history of IgA vasculitis should be carefully followed up after receiving the vaccine.